#NIAAA

Sdílet
Vložit
  • čas přidán 24. 07. 2024
  • Presented on June 7, 2018, at the University of Utah School of Medicine, this webinar featuring Dr. George F. Koob, director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), addresses the prevention, diagnosis, and treatment of alcohol use disorders (AUD).
    For more information about the National Institute on Alcohol Abuse and Alcoholism, visit niaaa.nih.gov.
  • Věda a technologie

Komentáře • 4

  • @timothybucky7170
    @timothybucky7170 Před 6 lety

    The anti-smoking drug varenicline (marketed under the name Chantix) significantly reduced alcohol consumption and craving among people with alcoholism.
    Gabapentin, a medication used to treat pain conditions and epilepsy, was shown to increase abstinence and reduce heavy drinking. Those taking the medication also reported fewer alcohol cravings and improved mood and sleep.
    The anti-epileptic medication topiramate was shown to help people curb problem drinking, particularly among those with a certain genetic makeup that appears to be linked to the treatment’s effectiveness.

  • @Ghtr5623
    @Ghtr5623 Před 10 měsíci

    Im disgusted that not one doctor offered me Chantix or Zyban for my heavy 47 yr addiction to 30 cigs a day. Im amazed im actually still alive. All they offer is nicotine patches and similar. None worked. My addiction to cigs has caused me more distress and financial than my alcohol addiction ever did. I stopped drinking but cigs are killing me and costing me more than i can afford. When my savings run out ill probably seek euthsnasia unless i stop somehow.

  • @ctwatcher
    @ctwatcher Před 6 lety

    We're trying to drink ourselves to death now so all the special little groups of mentally ill people can be followed to see how they treat each other as inquiring tax thieves want to know! Bringing good life for a few tax thieves. Tear it down. No institute for health in this nation now.

  • @frankomamani5245
    @frankomamani5245 Před 6 lety

    LOL